Angiotensin receptor blockade increases pancreatic insulin secretion and decreases glucose intolerance during glucose supplementation in a model of metabolic syndrome

Endocrinology

Volumn 153, Issue 4, 2012, Pages 1684-1695

  Rodriguez, Ruben ^a   Viscarra, Jose A ^a   Minas, Jacqueline N ^a   Nakano, Daisuke ^b   Nishiyama, Akira ^b   Ortiz, Rudy M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR TYPE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; INSULIN; OLMESARTAN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE INTAKE; GLUCOSE INTOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SUPPLEMENTATION;

ADIPOSE TISSUE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; GLUCOSE; GLUCOSE INTOLERANCE; INSULIN; LEPTIN; MALE; METABOLIC SYNDROME X; MUSCLE, SKELETAL; PANCREAS; RATS; RATS, INBRED OLETF; RATS, INBRED STRAINS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, GLUCAGON; TRIGLYCERIDES;

EID: 84859393335     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1885     Document Type: Article

References (41)

1. Iwai M, Kanno H, Tomono Y, Inaba S, Senba I, Furuno M, Mogi M, Horiuchi M 2010 Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-Ay mice. J Hypertens 28:1471-1481
2. Lee MH, Song HK, Ko GJ, Kang YS, Han SY, Han KH, Kim HK, Han JY, Cha DR 2008 Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue. Kidney Int 74:890-900
3. Nagai Y, Ichihara A, Nakano D, Kimura S, Pelisch N, Fujisawa Y, Hitomi H, Hosomi N, Kiyomoto H, Kohno M, Ito H, Nishiyama A 2009 Possible contribution of the non-proteolytic activation of prorenin to the development of insulin resistance in fructose-fed rats. Exp Physiol 94:1016-1023
4. Habibi J, Whaley-Connell A, Hayden MR, DeMarco VG, Schneider R, Sowers SD, Karuparthi P, Ferrario CM, Sowers JR 2008 Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 Rt. Endocrinology 149:5643-5653
5. Chu KY, Lau T, Carlsson PO, Leung PS 2006 Angiotensin II type 1 receptor blockade improves β-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 55:367-374 (Pubitemid 43343265)
6. Gilliam-Davis S, Payne VS, Kasper SO, Tommasi EN, Robbins ME, Diz DI 2007 Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats. Am J Physiol Heart Circ Physiol 293:H1327-H1333 (Pubitemid 47367170)
7. Yuan L, Li X, Li J, Li H-l, Cheng S-s 14 July 2010 Effects of reninangiotensin system blockade on the islet morphology and function in rats with long-term high-fat diet. Acta Diabetol 10.1007/s00592-010-0210-8
8. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME 2004 Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 53:989-997 (Pubitemid 38436611)
9. Abuissa H, Jones PG, Marso SP, O'Keefe Jr JH 2005 Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 46:821-826 (Pubitemid 41224805)
10. Ahrén B 1998 Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes. Bioessays 20:642-651 (Pubitemid 28422224)
11. Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB 2010 Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes. Diabetes Care 33:2477-2483
12. Ford ES, Giles WH, Dietz WH 2002 Prevalence of the metabolic syndrome among U.S. adults. JAMA 287:356-359
13. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB 2005 Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112:3066-3072 (Pubitemid 43113437)
14. Hanson RL, Imperatore G, Bennett PH, Knowler WC 2002 Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51:3120-3127
15. Baron AD, Brechtel G, Wallace P, Edelman SV 1988 Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol Endocrinol Metab 255:E769-E774
16. Laye MJ, Rector RS, Warner SO, Naples SP, Perretta AL, Uptergrove GM, Laughlin MH, Thyfault JP, Booth FW, Ibdah JA 2009 Changes in visceral adipose tissue mitochondrial content with type 2 diabetes and daily voluntary wheel running in OLETF rats. J Physiol 587:3729-3739
17. Iba A, Kohjimoto Y, Mori T, Kuramoto T, Nishizawa S, Fujii R, Nanpo Y, Matsumura N, Shintani Y, Inagaki T, Hara I 2010 Insulin resistance increases the risk of urinary stone formation in a rat model of metabolic syndrome. BJU Int 106:1550-1554
18. Mizukawa M, Ohmori K, Obayashi A, Ishihara Y, Yoshida J, Noma T, Yukiiri K, Kosaka H, Kohno M 2009 Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model. Hypertens Res 32:617-624
19. Heller-Harrison RA, Morin M, Czech MP 1995 Insulin regulation of membrane-associated insulin receptor substrate 1. J Biol Chem 270:24442-24450
20. Leney SE, Tavaré JM 2009 The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets. J Endocrinol 203:1-18
21. Taniyama Y, Hitomi H, Shah A, Alexander RW, Griendling KK 2005 Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II. Arterioscler Thromb Vasc Biol 25:1142-1147 (Pubitemid 40776600)
22. Ogihara T, Asano T, Ando K, Chiba Y, Sakoda H, Anai M, Shojima N, Ono H, Onishi Y, Fujishiro M, Katagiri H, Fukushima Y, Kikuchi M, Noguchi N, Aburatani H, Komuro I, Fujita T 2002 Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension 40:872-879 (Pubitemid 35434909)
23. Hotamisligil G, Shargill NS, Spiegelman BM 1993 Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91 (Pubitemid 23036092)
24. Kershaw EE, Flier JS 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556 (Pubitemid 38766330)
25. Carlsson PO, Berne C, Jansson L 1998 Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 41:127-133 (Pubitemid 28088387)
26. Lau T, Carlsson PO, Leung PS 2004 Evidence for a local angiotensin- generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47:240-248 (Pubitemid 38315360)
27. Leung PS, Chan HC, Fu LX, Wong PY 1997 Localization of angiotensin II receptor subtypes AT1 and AT2 in the pancreas of rodents. J Endocrinol 153:269-274 (Pubitemid 27219459)
28. Kreymann B, Ghatei MA, Williams G, Bloom SR 1987 Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2:1300-1304 (Pubitemid 17156636)
29. Kieffer TJ, McIntosh CH, Pederson RA 1995 Degradation of glucose- dependent insulinotropic polypeptide and truncated glucagonlike peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136:3585-3596
30. Henriksen EJ, Jacob S, Kinnick TR, Teachey MK, Krekler M 2001 Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension 38:884-890 (Pubitemid 34258687)
31. Muñoz MC, Argentino DP, Dominici FP, Turyn D, Toblli JE 2006 Irbesartan restores the in vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. J Hypertens 24:1607-1617 (Pubitemid 44162463)
32. Muñoz MC, Giani JF, Dominici FP, Turyn D, Toblli JE 2009 Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats. J Hypertens 27:2409-2420
33. Shiuchi T, Cui TX, Wu L, Nakagami H, Takeda-Matsubara Y, Iwai M, Horiuchi M 2002 ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO. Hypertension 40:329-334 (Pubitemid 35006719)
34. Shiuchi T, Iwai M, Li HS, Wu L, Min LJ, Li JM, Okumura M, Cui TX, Horiuchi M 2004 Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Hypertension 43:1003-1010 (Pubitemid 38579905)
35. Sloniger JA, Saengsirisuwan V, Diehl CJ, Kim JS, Henriksen EJ 2005 Selective angiotensin II receptor antagonism enhances whole-body insulin sensitivity and muscle glucose transport in hypertensive TG-(mREN2)27 rats. Metabolism 54:1659-1668 (Pubitemid 41728160)
36. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G 2003 Adiponectin expression from human adipose tissue. Diabetes 52:1779-1785
37. Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, Laplante M, Nawrocki AR, Rajala MW, Parlow AF, Cheeseboro L, Ding YY, Russell RG, Lindemann D, Hartley A, Baker GR, Obici S, Deshaies Y, Ludgate M, Rossetti L, Scherer PE 2004 A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145:367-383 (Pubitemid 38094532)
38. Lee JW, Nam-Goong IS, Kim JG, Yun CH, Kim SJ, Choi JI, Kim YI, Kim ES 2010 Effects of rosiglitazone on inflammation in Otsuka Long-Evans Tokushima fatty rats. Kor Diabetes J 34:191-199
39. Choi KC, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH, Choi KM 2005 Effect of PPAR-α and -γ agonist on the expression of visfatin, adiponectin, and TNF-α in visceral fat of OLETF rats. Biochem Biophys Res Commun 336:747-753 (Pubitemid 41338332)
40. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P 1995 Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549
41. Niimi M, Sato M, Yokote R, Tada S, Takahara J 1999 Effects of central and peripheral injection of leptin on food intake and on brain fos expression in the Otsuka Long-Evans Tokushima fatty rat with hyperleptinaemia. J Neuroendocrinol 11:605-611 (Pubitemid 29338676)